CVS March Comps up 7.5%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Wall Street rises with investors rotating into healthcare and value stocks
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $94.64 +2.11%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.8%
Revenue Growth %: +1.8%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.8%
Revenue Growth %: +1.8%
Join SI Premium – FREE
CVS Corporation (NYSE: CVS) said same store sales (sales from stores open more than one year) for the five weeks ended April 2, 2005 increased 7.5% over the prior year period
You May Also Be Interested In
- MinuteClinic® opens three new retail medical clinics to serve Massachusetts patients
- Revolve Group names Dwyane Wade as Chief Performance Officer
- HSBC Reiterates Reduce Rating on CoreWeave (CRWV), 'Expensive valuation'
Create E-mail Alert Related Categories
Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
